NORML

MAY 23, 2023

The post DEA Reports More Marijuana Seizures, Fewer Arrests in 2022 appeared first on NORML. Federal law enforcement agents and their partners seized nearly 5.7 million cultivated marijuana plants in 2022. This is the highest annual seizure total reported by the agency since 2011.

DEA 208

DEA Marijuana Cultivation Law 208

NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 196

DEA Cultivation Compliance Compliance 196

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 355

Cultivation DEA Clinical Trials Marijuana 355

NORML

JULY 16, 2019

Federal agents seized fewer total marijuana plants in 2018, but made more arrests for cannabis-related offenses, according to annual data compiled by the US Drug Enforcement Administration. Adult-use retail sales of cannabis began in California in 2018. million marijuana plants nationwide in 2018. million in 2017 to 1.4

DEA 185

DEA Marijuana Data Retail 185

Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.

Patients 111

Patients DEA Research and Development Recreational 111

Leafly

MAY 18, 2021

Hello, real-world high-quality cannabis. The post DEA finally ends fed monopoly on schwaggy research-grade cannabis appeared first on Leafly. Goodbye, Mississippi ditch weed.

DEA 145

DEA Cannabis 145

Americans for Safe Access

JULY 24, 2024

Now that public comment has closed the rescheduling process shifts to the Drug Enforcement Administration (DEA).

DEA 290

DEA Access Cannabis 290

Leafly

JUNE 8, 2020

The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly.

DEA 145

DEA Marijuana Cannabis 145

Leafly

OCTOBER 17, 2022

The Drug Enforcement Administration wants to increase the amount of cannabis and psychedelics it researches in 2023. The post DEA wants to boost production of cannabis and psychedelics research in 2023? appeared first on Leafly.

DEA 142

DEA Cannabis 142

Medical Marijuana Pages

OCTOBER 9, 2024

DEA Potential Reclassification of Marijuana Policy. In recent discussions surrounding drug policy reform, the reclassification of marijuana by the Drug Enforcement Administration (DEA) has emerged as a pivotal issue. Read More

DEA 122

DEA Policy Marijuana Cannabis 122

Americans for Safe Access

MARCH 12, 2025

Watch as we explore the significance of the last 12 years in establishing cannabis' "currently accepted medical use" and learn why this matters! Watch as we explore the significance of the last 12 years in establishing cannabis' "currently accepted medical use" and learn why this matters!

DEA 130

DEA Policy Cannabis 130

NORML

MARCH 26, 2020

For the second time in four years, the US Drug Enforcement Administration is proposing regulatory changes to procedures governing the federally licensed manufacture of cannabis for clinical research purposes. The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants.

Cultivation 241

Cultivation DEA Extraction THC 241

Americans for Safe Access

JUNE 2, 2020

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

Clinical Trials 264

Clinical Trials DEA History Programs 264

Americans for Safe Access

APRIL 19, 2022

When we started Americans for Access, we were facing paramilitary style raids from the DEA, only 8 states had passed laws creating criminal exemptions for medical cannabis patients, the DEA was still saying that cannabis was a gateway drug and there was no legal access anywhere!

DEA 264

DEA Access Patients Law 264

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety. A Vicious Circle.

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

Leafly

AUGUST 26, 2019

Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly.

DEA 111

DEA Cannabis 111

Cannabis Law Report

DECEMBER 3, 2020

The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. Drug Enforcement Administration reiterated that a lawsuit challenging marijuana’s classification as a Schedule 1 drug under the federal Controlled Substances Act should be … Read More.

DEA 114

DEA Cannabis Law 114

NORML

JULY 15, 2020

Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.". The post Survey: Majority of Health Care Professionals Endorse Cannabis Use Instead of Opioids in Chronic Pain Patients appeared first on NORML.

Chronic Pain 246

Chronic Pain Patients DEA Marijuana 246

Leafly

AUGUST 19, 2019

The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Yes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.

DEA 111

DEA Cannabis 111

Veriheal

OCTOBER 20, 2021

Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production. million grams, according to reporting by Marijuana Moment.

DEA 98

DEA Cultivation Cannabis Marijuana 98

NORML

OCTOBER 21, 2019

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.

DEA 104

DEA Cultivation Clinical Trials Policy 104

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.

Clinical Trials 235

Clinical Trials Legislation DEA Patients 235

NORML

JANUARY 16, 2020

The 2019 end-of-year report finds that the number of federal defendants charged with cannabis-associated crimes declined by 28 percent. Separate data reported by the US Drug Enforcement Administration in July reported a decline in DEA-led marijuana seizures, but showed an increase in DEA arrests for marijuana violations in 2018.

DEA 253

DEA Marijuana Data Cannabis 253

Cannabis Law Report

AUGUST 27, 2021

The language is general but it looks like the DEA will be trying to nip supply in the bud at source. WASHINGTON – The Drug Enforcement Administration today announced a comprehensive review of DEA’s international operations and foreign footprint, including administrative and financial support for those operations from DEA headquarters.

DEA 105

DEA Safety Programs Law 105

Veriheal

APRIL 25, 2024

One Arizona church, known as the Church of the Eagle and the Condor (CEC), recently settled a lawsuit with the Drug Enforcement Agency (DEA), the Department of Homeland Security (DHS), and other federal agencies. The DEA will also take samples of shipments to ensure that the only substance entering the country is ayahuasca.

DEA 111

DEA History Access Medicine 111

Cannabis Law Report

OCTOBER 27, 2020

A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More.

DEA 98

DEA Law Marijuana Cannabis 98

Project CBD

MARCH 7, 2025

13 by the San Diego/Imperial Counties Joint Labor Management Cannabis Committee made up of representatives of UFCW Local 135 , and local companies March & Ash and Embarc. What’s more, synthesized Delta-9 THC is present in many of these products, despite being prohibited in both California’s cannabis and hemp programs.

Hemp 232

Hemp Vaping THC Cannabinoids 232

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling. That one was granted.

DEA 108

DEA Marijuana History Cannabis 108

Veriheal

JANUARY 24, 2023

As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. So what gives?

DEA 98

DEA Treatment Medicine Pets 98

Cannabis Law Report

SEPTEMBER 1, 2021

The lawsuit—filed last year by cannabis researcher Sue Sisley of the Scottsdale Research Institute, the Battlefield Foundation and veterans Lorenzo Sullivan and Gary Hess— received oral arguments in June and largely centers on DEA’s 2020 denial of a one-page marijuana rescheduling petition filed by a separate individual.

DEA 109

DEA Marijuana Policy Cannabis 109

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. .”

DEA 197

DEA Research and Development Clinical Trials Marijuana 197

Cannabis Law Report

DECEMBER 18, 2020

SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to facilitate the cultivation of … Read More. The post Document – DEA: Controls To Enhance the Cultivation of Marihuana for Research in the United States first appeared on Cannabis Law Report. ACTION: Final rule.

DEA 105

DEA Cultivation Law Cannabis 105

Cannabis Law Report

JUNE 14, 2023

Marijuana Moment The Drug Enforcement Administration (DEA) is weighing in on the legal status of lesser known cannabinoids such as THCA, delta-8 THC and hydrogenated CBD.

DEA 98

DEA Cannabinoids CBD Legalization 98

Cannabis Law Report

AUGUST 12, 2021

Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. US DEA , No. In what could be a groundbreaking case for psychedelic medicine, VS counsel Shane Pennington is part of a team working on an exciting and very important Ninth Circuit challenge to the U.S.

DEA 105

DEA Medicine Food Patients 105

Cannabis Law Report

SEPTEMBER 1, 2020

The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More. The post Document: Court Orders California to Give Cannabis Records to DEA first appeared on Cannabis Law Report.

DEA 85

DEA Hemp Cannabis Law 85

Cannabis Law Report

AUGUST 12, 2021

Aurum Labs ( [link] ) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration. Aurum has always been at the forefront of cannabis and hemp testing.

DEA 98

DEA Hemp Compliance Compliance 98